Volume 64, Issue 4, Pages (April 2016)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 66, Issue 4, Pages (April 2017)
Part I: Liver function in oncology: biochemistry and beyond
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 51, Issue 3, Pages (September 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
The management of childhood liver diseases in adulthood
Volume 49, Issue 5, Pages (November 2008)
Immigration and viral hepatitis
Volume 42, Issue 4, Pages (April 2005)
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 63, Issue 1, Pages (July 2015)
Adult hepatoblastoma: Learning from children
Volume 44, Issue 5, Pages (May 2006)
Hepatitis C core protein – The “core” of immune deception?
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
Jay A. Graham, James V. Guarrera  Journal of Hepatology 
What is the long-term outcome of the liver allograft?
Volume 57, Issue 2, Pages (August 2012)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Unmet clinical need in autoimmune liver diseases
Volume 55, Issue 1, Pages (July 2011)
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
De novo autoimmune hepatitis after liver transplantation
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy  Lieve Claes, Jurgen Del-Favero, Berten Ceulemans, Lieven.
An autosomal dominant form of non-cirrhotic portal hypertension
Fibrosis in chronic liver diseases: diagnosis and management
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Fen Huang, Chenchen Yang, Xinying Zhou, Wenhai Yu, Qiuwei Pan 
Paul C. Adams, James C. Barton  Journal of Hepatology 
Portal vein thrombosis, cirrhosis, and liver transplantation
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 4, Pages (April 2006)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
HCV targeting of patients with cirrhosis
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 39, Issue 2, Pages (August 2003)
Volume 51, Issue 2, Pages (August 2009)
Volume 64, Issue 1, Pages (January 2016)
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?  Jingzhi Cai, Wengang Guo, Chuangye.
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
Volume 58, Issue 2, Pages (February 2013)
The relationship between age and fat infiltration in liver and muscle
Presentation transcript:

Volume 64, Issue 4, Pages 974-977 (April 2016) A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non- cirrhotic portal hypertension  Bart G.P. Koot, Marielle Alders, Joanne Verheij, Ulrich Beuers, Jan M. Cobben  Journal of Hepatology  Volume 64, Issue 4, Pages 974-977 (April 2016) DOI: 10.1016/j.jhep.2015.11.027 Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions

Fig. 1 Family pedigree. Journal of Hepatology 2016 64, 974-977DOI: (10.1016/j.jhep.2015.11.027) Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions

Fig. 2 Liver histology of girl. (A) Sclerotic portal tract (arrow); PAS-amylase staining, 20×. (B) Portal tract with bile duct (∗), hepatic artery (#) and thickening of muscle wall ‘arterialisation’ of the portal vein (+); AZAN staining, 20×. Liver histology of father: (C) Portal tract with increased number of vessels, portal vein dilatation (∗) and paraportal shunting vessels (#); Elastica von Giesson staining, 10×. (D) Abnormal spacing of parenchymal venous structures (∗); Haematoxylin and Eosin staining, 4×. Journal of Hepatology 2016 64, 974-977DOI: (10.1016/j.jhep.2015.11.027) Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions

Fig. 3 Sanger sequencing confirms the presence of the de novo mutation in KCNN3 in II-2 and transmission to his three affected children. Journal of Hepatology 2016 64, 974-977DOI: (10.1016/j.jhep.2015.11.027) Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions

Fig. 4 Structure of the SK channel consisting of six transmembrane domains, a pore region (P) between S5 and S6, and calmodulin interacting with the channel’s intracellular COOH terminus. The mutation changes a conserved residue in the intracellular loop between the 4th and 5th transmembrane segment. Adapted from Ledoux et al. 2006 with permission. Journal of Hepatology 2016 64, 974-977DOI: (10.1016/j.jhep.2015.11.027) Copyright © 2015 European Association for the Study of the Liver. Terms and Conditions